Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab
暂无分享,去创建一个
S. Matsumoto | K. Goto | K. Kunimasa | F. Imamura | M. Tamiya | T. Kumagai | H. Kuhara | Takako Inoue | K. Nishino | H. Kawachi | K. Kuno